Footer Twenty Six

Indian Pharma 2030 – Export & Investment Opportunities


SUMMARY

India is the world’s largest producer of quality and affordable generic medicines. India has recently also emerged as the largest producer of affordable vaccines in the world. Generic pharmaceutical export is one of the few areas where India has a vast lead over China. India is the world’s largest producer of quality and affordable generic medicines

New opportunities will open for India in the coming decade. This includes vast opportunities for API exports, Contract Research & Manufacturing Organisations, plant-based medicinal & health products, complex generics and biogenerics. In addition, due to pandemic disruptions in supply of medicines, many countries in Africa as well as The European Union etc. are offering unprecedented opportunities in overseas manufacturing of generics along with favourable funding options.

This workshop will provide an overview of these opportunities which are opening up for Indian entrepreneurs in global markets.

FOR WHOM
Pharma Industries, Entrepreneurs, MSMEs, Existing and Aspiring Exporters

Date: Jun-19, 2026
Mode: On Campus
Faculty: Mr. Suhayl Abidi
Timing: 2.00 PM to 5.00 PM
Fees (Incl. 18% GST): ₹500


Program details

Date & Time
June 19, 2026
2:00 pm – 5:00 pm
Venue
Ahmedabad Management Association Dr. Vikram Sarabhai Marg, ATIRA Campus, Vastrapur View Map →
Category
EXIM
Organised under
GoG-AMA Centre for International Trade, Industries Commissionerate, Govt of Gujarat
Register Now
Past
₹500.00
Program Ended This program has ended. Registration is no longer available.

Upcoming Related Programs